The new vaccines that are yet to arrive in 2021 (and their stock market status)

We analyze the laboratories that are going to launch their respective vaccines throughout (except for delays) in 2021. Some action is more interesting than others but in most we see a clear technical aspect with an upward trend that can continue with the exit of their serums.

The order of analysis is as follows: SANOFI y GLAXOSMITHKLINE (GSK) that can ship their products later this year. Something closer in time and with their respective delays, they are NOVAVAX, CUREVAC y VALNEVA. In the video we mark the technical levels and most relevant structures of these actions that will soon be on everyone’s lips.


See also  Scientists Find Fossilized Bat Dung 4,300 Years Ago

Leave a Comment